| Tag | Content |
|---|
EnhancerAtlas ID | HS127-15186 |
Organism | Homo sapiens |
Tissue/cell | Macrophage |
Coordinate | chr19:16510060-16510990 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr19:16510931-16510946 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10209 | chr19:16508040-16511009 | CD19_Primary | | SE_11315 | chr19:16506924-16513093 | CD20 | | SE_61491 | chr19:16432573-16510994 | Toledo | | SE_62295 | chr19:16434424-16512260 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I016396 | chr19 | 16507590 | 16510945 |
|
Enhancer Sequence | AATCAGAGTG GGAAACGAGA TTTCCCTGTT ACAAAGATAC CATCAACTCT ACCCCTTGCA 60
GACCACCTAC TAAGGAGAAC AGACCCATCT GCCAACTTGG GGGACACGAG TACAGCAGAC 120
AAGGGCCAGG ATGAATGACA CGGCCCTTGG CAGAGATGTA ATATCTTGAA CAAGTTCAGC 180
AACCAGTGTG AAGTTGTACC CTTCTTAGGA AATACACACG GCAACTCTGA AAGGGGGCTG 240
AAGAAGCTTC TGTGACATTC CCGCCCTTTA GAGGAGTGCT GGGCAGCAGG GGTGTGCTGG 300
GAATCAGTTC TCTCAGAAAA AAGCCCTGGT TTAGAGCTTC TGCCAATTCC TGTGGTGTAA 360
ACAGTCTCAT CATGGTTGAT TTCAAGTTTC CAAGCAACTA GCTCACAAGT TCCTGTTTTT 420
TGCTTTTTGG GGTTTTTTTT TTTTTTTTAG AGATTGAGTC TCGCTGTGTC ACCCAGGCTG 480
GAGTGCAGTG GCACGCAGCT GGCCTCAAGC AATCCTCCCA CCTCAGCCTC CCAAAGGACT 540
GGGATTACAG GTGTGAGCCA TTGTGCCCGG CCAGTTCCTA TTTAATAATC GGTTCTGGAA 600
AGTCAATAAA AACTGGCTCC AGCATGCCAC TGGGTCTGGA TGTGACAGAT CAATCAACCT 660
TTCTTAATCT GTCCTCAGTA AGGCCTAAGT CTGGGATGAT TTATTAGCTT CTCTCCATAA 720
GTTGATTGGA TGGTGAGCAA GAGGTCAATA TTCTCATAAT CAGATGATAG ACAAGAAATA 780
AATATGGCTT TAAGAACCCT GACTTTGGCG GGTGAGGTGG CTCACGCCTG TAATCCCAGC 840
ATTTGGGGAG GTCGAGGCGG GCAGATTGCC TGAGGTCAGG AGTTCAAGAC CAGCCTGGGC 900
AACACTGTGA AACCTCGTCT CTACTAAAAA 930
|
